CRYSTAL-STRUCTURES OF ALPHA-FUNALTREXAMINE AND BETA-FUNALTREXAMINE - CONFORMATIONAL REQUIREMENT OF THE FUMARAMATE MOIETY IN THE IRREVERSIBLE BLOCKAGE OF MU-OPIOID RECEPTORS

被引：28

作者：

GRIFFIN, JF ^{[1
]}

LARSON, DL ^{[1
]}

PORTOGHESE, PS ^{[1
]}

机构：

[1] UNIV MINNESOTA,COLL PHARM,DEPT MED CHEM,MINNEAPOLIS,MN 55455

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1986年 / 29卷 / 05期

关键词：

D O I：

10.1021/jm00155a031

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：778 / 783

页数：6

共 23 条

[1] GEOMETRICAL REACTION COORDINATES .2. NUCLEOPHILIC ADDITION TO A CARBONYL GROUP [J].

BURGI, HB ;

DUNITZ, JD ;

SHEFTER, E .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1973, 95 (15) :5065-5067

[2] SOLUTION CONFORMATIONS OF THE 6-ALPHA-EPIMER AND 6-BETA-EPIMER OF OXYMORPHAMINE [J].

CROUCH, RC ;

BHATIA, AV ;

LEVER, OW .

TETRAHEDRON LETTERS, 1983, 24 (44) :4801-4804

[3] STRUCTURAL STUDIES OF SUBSTITUTED 6,7-BENZOMORPHAN COMPOUNDS .1. ABSOLUTE-CONFIGURATION OF (-)-2-CYCLOPROPYLMETHYL-2'-HYDROXY-5-ETHYL-9,9-DIMETHYL-6,7-BENZOMORPHAN (GEMAZOCINE) HYDROBROMIDE [J].

GELDERS, YG ;

DERANTER, CJ ;

SCHENK, H .

ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1979, 35 (MAR) :699-703

[4]

GRIFFIN JF, 1984, 13TH C IUCR HAMB

[5]

IIJIMA I, 1977, HETEROCYCLES, V6, P1157

[6] CRYSTAL AND MOLECULAR-STRUCTURE OF 6-DEOXY-6-AZIDO-14-HYDROXYDIHYDROISOMORPHINE, C17H20N4O3 [J].

KALMAN, A ;

IGNATH, Z ;

SIMON, K ;

BOGNAR, R ;

MAKLEIT, S .

ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1976, 32 (SEP15) :2667-2670

[7] CONFORMATION OF NALOXONE, A NARCOTIC-ANTAGONIST [J].

KARLE, IL .

ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1974, B 30 (JUL15) :1682-1686

[8] CRYSTAL STRUCTURES OF DL-CYCLAZOCINE AND L-CYCLAZOCINE.HBR.H2O, AND ABSOLUTE CONFIGURATION OF L-CYCLAZOCINE.HBR.H20(2-CYCLOPROPYLMETHYL-2'-HYDROXY-5,9-DIMETHYL-6,7-BENZOMORPHAN) [J].

KARLE, IL ;

GILARDI, RD ;

FRATINI, AV ;

KARLE, J .

ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL CRYSTALLOGRAPHY AND CRYSTAL CHEMISTRY, 1969, B 25 :1469-&

[9] NOVEL OPIOID RECEPTOR-SITE DIRECTED ALKYLATING AGENT WITH IRREVERSIBLE NARCOTIC ANTAGONISTIC AND REVERSIBLE AGONISTIC ACTIVITIES [J].

PORTOGHESE, PS ;

LARSON, DL ;

SAYRE, LM ;

FRIES, DS ;

TAKEMORI, AE .

JOURNAL OF MEDICINAL CHEMISTRY, 1980, 23 (03) :233-234

[10]

PORTOGHESE PS, 1984, NATURAL PRODUCTS DRU, P421

← 1 2 3 →